Thanks CJ! I have some information to read instead of my reaching to the ends of the internet to pull some speculations out : )
GLTA!
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!